期刊文献+

CD133 和 CD44 在胃腺癌中的表达及其与 E-cadherin 的关系 被引量:12

Expressions of CD133 and CD44 in gastric adenocarcinoma and their relationship with Ecadherin expression
下载PDF
导出
摘要 目的探讨原发性胃腺癌(gastric adenocarcinoma,GAC)组织中CD133、CD44和E-cadherin蛋白表达的关系及临床病理意义。方法应用免疫组织化学ElivisionTMplus法检测145例胃腺癌组织和30例正常胃黏膜组织中CD133、CD44和E-cadherin蛋白的表达。结果在正常胃黏膜组织中,CD133、CD44和E-cadherin蛋白的阳性表达率分别为10.0%、3.3%和100%;在GAC组中,CD133、CD44和E-cadherin蛋白的阳性表达率分别为46.9%、47.6%和42.8%,两组之间,差异均有显著性(P<0.05)。CD133、CD44和E-cadherin蛋白的表达水平均与肿瘤的大小、分化程度、淋巴结转移与否、浸润深度、临床分期及术后生存期有关(全部P<0.05);CD133的表达与CD44的表达呈正相关(P<0.05),CD133和CD44的表达均与E-cadherin的表达呈负相关(P<0.005)。Kaplan-Meier生存分析表明,CD133和CD44蛋白表达阳性的患者其生存率明显低于其阴性表达患者(P<0.001);Ecadherin蛋白表达阳性的患者其生存率明显高于其阴性表达患者。Cox回归分析:CD133、CD44和E-cadherin的表达是影响GAC患者术后生存率的独立预后因素。结论 CD133、CD44和E-cadherin的表达水平在GAC组织中与肿瘤组织的大小、分化程度、临床分期、浸润深度、淋巴结转移与否及预后等均有关;在GAC组织中联合检测CD133、CD44和E-cadherin对判断预后有价值。 Objective To explore the expression of CD133 and CD44 in the primary gastric adenocarcinoma (GAC) and their relationship with the expression of E-cadherin. Methods The expressions of CD133, CD44, and E-cadherin was examined by immunohistochemistry in 145 specimens of GAC tissues and 30 specimens of normal gastric tissues. Results The positivity rates of CD133, CD44, and E-cadherin in normal gastric tissues were 10.0% , 0%, and 100%, respectively, showing significant differences from the rates in GAC tissues (46.9%, 47.6%, and 42.8%, respectively) (P〈0.05). The expressions of CD133, CD44, and E-cadherin were significantly related with the tumor volume, differentiation, lymph node metastasis, invasive depth, pathologic-tumor-node-metastasis (pTNM) stages, and postoperative-survival time (all P〈0.05); a positive correlation was found between the expression of CD133 and CD44, and they were both negatively correlated with E-cadherin expression (P〈 0.005). Kaplan-Meier analysis showed a significant difference in the survival rate between CD133-positive and CD133-negative patients (P〈0.001) and between CD44-positive and CD44-negative patients; the patients with positive expression of E-cadherin had a significantly longer survival than those negative for E-cadherin. Cox regression analysis indicated that CD133, CD44, and E-cadherin expressions were all independent prognostic factors of GAC (all P〈0.05). Conclusion The expressions of CD133, CD44, and E-cadherin are related to the tumor volume, differentiation, pTNM stages, invasive depth, lymph node metastasis, and prognosis of GAC, and their combined detection can be of important value in predicting the prognosis of GAC.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2013年第11期1632-1637,共6页 Journal of Southern Medical University
基金 安徽省高等学校优秀青年人才基金(2012SQRL095) 蚌埠医学院院级课题(Byky1337)
关键词 胃肿瘤 CD133 CD44 E-CADHERIN 肿瘤干细胞 预后 gastric neoplasms CD133 CD44 E-cadherin cancer stem cells prognosis
  • 相关文献

参考文献3

二级参考文献35

  • 1Horst D, Kriegl L, Engel J, Kirchner T, Jung A. CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer 2008; 99:1285-1289.
  • 2Kojima M, Ishii G, Atsumi N, Fujii S, Saito N, Ochiai A. Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study. Cancer Sci 2008; 99: 1578-1583.
  • 3Kemper K, Sprick MR, de Bree M, Scopelliti A, Vermeulen L, Hoek M, Zeilstra J, Pals ST, Mehmet H, Stassi G, Medema JP. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Cancer Res 2010; 70:719-729.
  • 4Kelm JM, Timmins NE, Brown CJ, Fussenegger M, Nielsen LK. Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol Bioeng 2003; 83:173-180.
  • 5Weiswald LB, Richon S, Validire P, Briffod M, Lai-Kuen R, Cordeli-res FP, Bertrand F, Dargere D, Massonnet G, Marangoni E, Gayet B, Pocard M, Bieche I, Poupon MF, BeUet D, Dangles-Marie V. Newly characterised ex vivo colospheres as a three-dimensional colon cancer cell model of tumour aggressiveness. Br J Cancer 2009; 101:473482.
  • 6Friedrich J, Seidel C, Ebner R, Kunz-Schughart LA. Spheroidbased drug screen: considerations and practical approach. Nat Protoc 2009; 4:309-324.
  • 7Du L, Wang H, He L, Zhang J, Ni B, Wang X, Jin H, Cahuzac N, Mehrpour M, Lu Y, Chen Q. CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res 2008; 14: 6751-6760.
  • 8Horst D, Scheel SK, Liebmarm S, Neumarm J, Maatz S, Kirchner T, Jung A. The cancer stem cell marker CD133 has high prognostic impact but unknown hanctional relevance for the metastasis of human colon cancer. J Pathol2009; 219:427-434.
  • 9Zhu L Gibson P, Currle DS, Tong Y, Richardson RJ, Bayazitov IT, Poppleton H, Zakharenko S, EUison DW, Gflbertson RJ. Prominin I marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 2009; 457:603-607.
  • 10Barker N, van Es J-H, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ, Clevers H. Identification of stem ceils in small intestine and colon by marker gene Lgr5. Nature 2007; 449:1003-1007.

共引文献53

同被引文献157

引证文献12

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部